Shaare Zedek Medical Center
Jerusalem, 91031, Israel
Completed
NCT Number: NCT00394797
Surgical Correction of Moderate Ischemic Mitral Regurgitation
The purpose of this study is to try and determine whether repair of moderate ischemic mitral regurgitation at the time of coronary bypass graft surgery (CABG) has an impact on survival.We will compare patients undergoing CABG + mitral repair or CABG only groups. Primary endpoints include late survival. Secondary endpoints include event free survival, symptoms, and echocardiographic outcomes.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- patients undergoing coronary bypass surgery who have moderate degree of ischemic MR
Exclusion criteria
- etiology of mitral regurgitation other than ischemic, degree of regurgitation other than moderate.
Treatment and study plan
mitral valve annuloplasty
ProcedurePrimary outcomes
-
survival at 1,5 and 10 years
Secondary outcomes
-
event free survival
-
symptoms
-
echocardiographic parameters
Sponsors and collaborators
Lead sponsor
Shaare Zedek Medical Center
Other
Registry information
Important dates
- First posted
- Nov 1, 2006
- Registry last updated
- Jun 1, 2011
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.